ASBP
HEALTHCAREAspire Biopharma Holdings Inc
$0.19-0.01 (-7.00%)PRE
Live · NASDAQ · May 9, Close
AI Insight
What's Moving ASBP Today?
No stock-specific AI insight has been generated for ASBP yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$0.12$35.01
$0.19
Fundamentals
Market Cap$934,490
P/E Ratio—
EPS$-16.38
Dividend Yield—
Dividend / Share—
ROE—
Profit Margin—
Debt / Equity—
Trading
Volume4.1M
Avg Volume (10D)—
Shares Outstanding5.0M
ASBP News
20 articles- Aspire Biopharma Holdings, Inc. Announces Approval Of Reverse Stock Split RatioYahoo Finance·May 7, 2026
- ASBP: A Platform Approach to Drug Delivery with an Unconventional Path to CommercializationYahoo Finance·Apr 30, 2026
- Aspire Biopharma Announces $5.0 Million Share Repurchase ProgramYahoo Finance·Apr 27, 2026
- Aspire Biopharma Announces Closing of Second and Final Tranche of $21 Million Private Placement by Select Investors; Secures Commitment Letter for $22.5M Credit Facility to Fund the DCS AcquisitionYahoo Finance·Apr 20, 2026
- Aspire Biopharma's Buzz Bomb(TM) Caffeine Company's Brand Ambassador, Ashley Paulson, to Attempt Fastest 100-Mile Treadmill Run at 2026 Boston Marathon ExpoYahoo Finance·Apr 17, 2026
- Aspire Biopharma Has Entered Into a Letter of Intent to Acquire a Leading Global Automotive Supplier With a 100+ Year History and $200M+ in 2025 RevenueYahoo Finance·Apr 16, 2026
- Aspire Biopharma's Buzz Bomb Caffeine Company Partners with Interwest Brokerage to Accelerate Retail ExpansionYahoo Finance·Apr 15, 2026
- Aspire Biopharma's Subsidiary Announces Agreement with TruLife Distribution to Drive National Retail ExpansionYahoo Finance·Mar 19, 2026
- Aspire Biopharma's Subsidiary, Buzz Bomb Caffeine Company, Appoints John Choe as Western Sales DirectorYahoo Finance·Mar 17, 2026
- Aspire Biopharma's Subsidiary to Feature BUZZ BOMB(TM) at The Health & Fitness Show 2026Yahoo Finance·Mar 12, 2026
- Aspire Biopharma's BUZZ BOMB(TM) Disrupts Energy Category with New Convenience Store PackYahoo Finance·Mar 10, 2026
- Aspire Biopharma Partners with Microsize to Develop Rapid-delivery Sublingual Powder Formulation of Alprazolam for Faster Anxiety ReliefYahoo Finance·Mar 3, 2026
- Aspire Biopharma's Buzz Bomb(TM) Caffeine Company Achieves Record Social Media Growth and Sales Surge Following World-Record Marathon SponsorshipYahoo Finance·Feb 25, 2026
- Aspire Biopharma Regains Full Compliance with Nasdaq Listing RequirementsYahoo Finance·Feb 20, 2026
- Aspire Biopharma's Buzz Bomb Caffeine Company Names ChicExecs as Public Relations Agency of RecordYahoo Finance·Feb 19, 2026
- Aspire Biopharma Files Provisional Patent Application for a Fast-Acting Sublingual Powder Formulation of Meclizine (Generic Dramamine(R))Yahoo Finance·Feb 17, 2026
- Aspire Biopharma Announces the Appointment of New Member to Its Board of DirectorsYahoo Finance·Feb 13, 2026
- Aspire Biopharma Files Provisional Patent Application for a Fast-Acting Sublingual Powder Formulation of Ondansetron (Generic Zofran(R))Yahoo Finance·Feb 12, 2026
- Aspire Biopharma Announces $21 Million Private Placement by Select Investors, Strengthening Balance Sheet, Capital Position, and Fortifying Shareholder Equity to Meet Nasdaq RequirementsYahoo Finance·Feb 11, 2026
- Aspire Biopharma Regains Compliance with Nasdaq Minimum Bid Price RequirementYahoo Finance·Feb 10, 2026
All 20 articles loaded
Price Data
Open$0.19
Previous Close$0.20
Day High$0.19
Day Low$0.18
52 Week High$35.01
52 Week Low$0.12
52-Week Range
$0.12$35.01
$0.19
Fundamentals
Market Cap$934,490
P/E Ratio—
EPS$-16.38
Dividend Yield—
Dividend / Share—
ROE—
Profit Margin—
Debt / Equity—
Trading
Volume4.1M
Avg Volume (10D)—
Shares Outstanding5.0M
About Aspire Biopharma Holdings Inc
Aspire Biopharma Holdings, Inc., early-stage biopharmaceutical company, engages in developing and marketing of disruptive technology for delivery mechanisms for do no harm drugs in the United States. The company is headquartered in Humacao, Puerto Rico.
Listed February 20, 2025
HEALTHCAREBIOTECHNOLOGY
Company Details
Security TypeStock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICBIOTECHNOLOGY
CIK—
Composite FIGI—
Share Class FIGI—